Ascendis Pharma A/SASND
那斯達克 · USD
209.79
-3.44
(-1.61%)
收盤 06/11 03:59 (UTC+8)
06/11 03:59 (UTC+8)
Ascendis Pharma A/SASND
209.79
-3.44
(-1.61%)
財務數據
損益表
- 1.38
- 0.96
- 0.36
- 0.58
- 1.74
- 1.01
- 1.58
- 2.14
- 2.48
- 2.47
- 186.68
- -30.36
- -62.46
- 60.66
- 200.72
- -41.95
- 56.55
- 35.17
- 15.85
- -0.36
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 246,601 | 247,500 | 213,634 | 158,045 | 100,954 | 173,916 | 57,833 | 35,998 | 95,894 | 137,702 |
營業成本 | 17,515 | 23,598 | 22,354 | 31,447 | 17,517 | 14,023 | 11,201 | 11,465 | 7,569 | 19,457 |
營業毛利 | 229,086 | 223,902 | 191,280 | 126,598 | 83,437 | 159,893 | 46,632 | 24,533 | 88,325 | 118,245 |
營業費用 | 204,274 | 217,460 | 180,283 | 179,549 | 187,649 | 159,510 | 143,375 | 157,790 | 137,470 | 154,856 |
研發費用 | 59,044 | 78,151 | 66,879 | 71,988 | 86,603 | 79,296 | 73,544 | 83,478 | 70,687 | 90,881 |
推銷及管理費用 | 145,230 | 134,998 | 111,687 | 105,710 | 101,046 | 78,781 | 68,129 | 72,295 | 66,783 | 63,975 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 24,812 | 6,442 | 10,997 | -52,951 | -104,212 | 383 | -96,743 | -133,257 | -49,145 | -36,611 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 67,255 | 20,538 | 19,721 | 33,018 | 44,786 | -4,984 | 16,059 | 19,624 | 77,161 | 8,425 |
稅前純益 | -48,177 | -26,705 | -57,372 | -35,007 | -93,565 | -37,384 | -98,178 | -109,151 | -128,527 | -81,088 |
所得稅 | -677,516 | 6,857 | 3,617 | 3,848 | 1,061 | 1,085 | 1,020 | 229 | 2,508 | 5,790 |
稅後純益 | 629,339 | -33,562 | -60,989 | -38,855 | -94,626 | -38,469 | -99,198 | -109,380 | -131,035 | -86,878 |
基本每股稅後盈餘(元) | 10.20 | - | -1.00 | -0.64 | -1.58 | -0.64 | -1.72 | -1.91 | -2.30 | -1.54 |
稀釋每股稅後盈餘(元) | 9.75 | - | -1.00 | -0.82 | -1.58 | -0.64 | -1.72 | -2.21 | -2.30 | -1.54 |
基本平均股數(千股) | 61681.00 | - | 60756.00 | 60454.00 | 60018.00 | 59785.00 | 57535.00 | 57345.00 | 56883.00 | 56560.00 |
稀釋平均股數(千股) | 64521.00 | - | 60756.00 | 63911.00 | 60018.00 | 59785.00 | 57535.00 | 60802.00 | 56883.00 | 56560.00 |
還原基本每股稅後盈餘(元) | 10.20 | - | -1.00 | -0.64 | -1.58 | -0.64 | -1.72 | -1.91 | -2.30 | -1.54 |
還原稀釋每股稅後盈餘(元) | 9.75 | - | -1.00 | -0.82 | -1.58 | -0.64 | -1.72 | -2.21 | -2.30 | -1.54 |
還原基本平均股數(千股) | 61,681 | - | 60,756 | 60,454 | 60,018 | 59,785 | 57,535 | 57,345 | 56,883 | 56,560 |
還原稀釋平均股數(千股) | 64,521 | - | 60,756 | 63,911 | 60,018 | 59,785 | 57,535 | 60,802 | 56,883 | 56,560 |
EBITDA(千元) | 23,298 | -1,343 | -33,632 | 2,319 | -44,234 | -37,893 | -77,745 | -85,139 | -46,889 | -67,686 |